Expert Opinion on Orphan Drugs

Expert Opin Orphan Drugs

2167-8707

Therapeutic Area

Health Economics/Outcomes Research, Pharmacogenetics & Pharmacogenomics, Pharmacology, Public Health, Rare Diseases

Biomedical Researchers, Clinicians, Epidemiologists, Patients, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Researchers, Scientists

Expert Opinion on Orphan Drugs [e-ISSN 2167-8707] is an international journal publishing rigorously peer-reviewed review articles and original papers on rare diseases and orphan drugs. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Orphan Drugs aims to draw a spotlight on diseases that do not have a high prevalence but have a huge impact on patients and their clinicians, through valuable and high-quality expert insights. In a field which is ever-growing and changing, Expert Opinion on Orphan Drugs is committed to acting as a reliable beacon of guidance and support for researchers, clinicians, patients and advocacy groups in order to optimise research, development, management and quality of life of rare disease patients. Articles focus on the following key areas: Diagnostics, pharmacogenomics and screening; Public health and epidemiology; Drug development; Lead generation and discovery; Early or late phase clinical trials; Regulatory issues; Post-marketing safety and treatment outcomes.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines